Comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 vs 4 5 Toe Cutaneous Syndactyly C5937268
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Impaired Androgen Production and 4 5 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
A disorder where androgen production is impaired in 46,XY individuals. Results in undervirilization and atypical genital development. Treated with hormone replacement and supportive care.
4 5 Toe Cutaneous Syndactyly C5937268
Webbing between the 4th and 5th toes, present from birth. Usually mild and often does not affect walking. Treatment is typically not needed unless symptoms develop.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
0-0
4 5 Toe Cutaneous Syndactyly C5937268
0-0
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
severe
4 5 Toe Cutaneous Syndactyly C5937268
mild
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
Chronic
4 5 Toe Cutaneous Syndactyly C5937268
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
No
4 5 Toe Cutaneous Syndactyly C5937268
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
reproductive
4 5 Toe Cutaneous Syndactyly C5937268
musculoskeletal
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
endocrine
4 5 Toe Cutaneous Syndactyly C5937268
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-impaired-androgen-production-C5679870 and 4-5-toe-cutaneous-syndactyly-C5937268 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 5 Toe Cutaneous Syndactyly C5937268 | Discriminating power |
|---|---|---|---|
| Genital development | May show undervirilization or atypical genital development in a 46,XY person. | No genital abnormality is described. | High |
| Toe appearance | Toe webbing is not part of the supplied description. | Skin webbing between the fourth and fifth toes is present from birth. | High |
| Functional impact | Described as severe and may require hormone replacement and supportive care. | Usually mild and often does not affect walking. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 when
Atypical genital development in a 46,XY individual
The supplied description centers on impaired androgen production and undervirilization.
High
Need for endocrine and supportive management
Hormone replacement and supportive care are described, without specifying doses.
Moderate
Reproductive or endocrine concern
The concept is categorized as reproductive and endocrine rather than a toe finding.
High
Choose 4 5 Toe Cutaneous Syndactyly C5937268 when
Isolated webbing of the fourth and fifth toes
This matches the described congenital cutaneous syndactyly.
High
No walking difficulty or symptoms
Treatment is typically unnecessary unless symptoms develop.
Moderate
Musculoskeletal congenital finding without endocrine features
The supplied category and body system differ from the left condition.
High
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 5 Toe Cutaneous Syndactyly C5937268 | Interpretation |
|---|---|---|---|
| Karyotype | The concept specifies a 46,XY karyotype, but testing strategy is not detailed. | No karyotype abnormality is established by the supplied description. | A karyotype result alone does not diagnose either condition. |
| Androgen-related endocrine evaluation | Impaired androgen production is central, but exact cutoffs are not supplied. | No endocrine abnormality is described. | Abnormal hormone results require clinician interpretation and are not a toe diagnosis. |
| Foot examination | No characteristic foot finding is supplied. | Clinical inspection shows skin webbing between the fourth and fifth toes. | Physical findings should be distinguished from laboratory abnormalities. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
- Outcome
- A chronic, potentially severe condition; exact outcomes are not established here.
- Factors
- Degree of undervirilization, endocrine findings, and supportive care may influence course.
4 5 Toe Cutaneous Syndactyly C5937268
- Outcome
- Usually mild, with walking often unaffected.
- Factors
- Symptom development may determine whether treatment is considered.
Time frame: Both are described as chronic and present from early life, but onset details are limited.
Prognosis should be individualized; no mortality or prevalence data are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization | Described as a result of impaired androgen production. Not described. Severity and associated features vary; no definitive symptom list is established here. |
| Walking difficulty | Not described. Often absent, but symptoms may occasionally develop. The source does not quantify how often function is affected. |
| Need for intervention | Hormone replacement and supportive care are described. Treatment is typically not needed unless symptoms occur. Specific procedures, doses, and outcomes are not supplied. |
Patient education highlights
- HighDifferent conditions
These findings involve different body systems and should not be treated as interchangeable diagnoses.
- HighSpecialist interpretation
A clinician should interpret genital, endocrine, genetic, and foot findings in context.
- MediumSymptom monitoring
New walking problems, pain, or concerns about development should prompt clinical review.